Litcius/Paper detail

Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening–detectable findings

Idit Maya, Liat Salzer Sheelo, Dana Brabbing‐Goldstein, Reut Matar, Sarit Kahana, Ifaat Agmon‐Fishman, Cochava Klein, Merav Gurevitch, Lina Basel‐Salmon, Lena Sagi‐Dain

2021American Journal of Obstetrics and Gynecology29 citationsDOI

Topics & Concepts

MedicinePrenatal screeningCopy-number variationPrenatal diagnosisAmniocentesisObstetricsPregnancyMicroarrayResidual riskFetusBioinformaticsGeneticsInternal medicineGenomeBiologyGeneGene expressionPrenatal Screening and DiagnosticsGenomic variations and chromosomal abnormalitiesFetal and Pediatric Neurological Disorders